{
    "address": "Solvegatan 41",
    "city": "Lund",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W1970K104",
    "description": "Camurus AB operates as a research based pharmaceutical company. The company is headquartered in Lund, Skane and currently employs 137 full-time employees. The company went IPO on 2015-12-03. The firm has a diversified research portfolio, which includes five products in clinical trials, and a number of additional product candidates in the pre-clinical phase. The Company\u2019s product pipeline represents a mix of in-house and partnered projects in different development phases. Camurus AB is the parent company of the Group, which comprises four legal entities, namely Camurus Inc, Cubosome Inc, Camurus Development AB and Bioimplant Scandinavia AB.",
    "employeeTotal": "137.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Pharmaceuticals",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Pharmaceuticals",
    "gsector": "Health Care",
    "gsubind": "Pharmaceuticals",
    "ipo": "2015-12-03",
    "isin": "SE0007692850",
    "logo": "https://finnhub.io/api/logo?symbol=CAMX.ST",
    "marketCapitalization": 12216.64,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Pharmaceutical Preparation Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Camurus AB",
    "phone": "46462865730.0",
    "sedol": "BYWKGQ3",
    "shareOutstanding": 54.23519,
    "state": "SKANE",
    "ticker": "CAMX.ST",
    "weburl": "https://www.camurus.com/"
}